Literature DB >> 31512046

Molecular evolution of single chain fragment variable (scFv) for diagnosis of lymphatic filariasis.

Natarajan Mahalakshmi1, Rajendran Ravishankaran2, Ramakrishnan Kamatchi1, Nikhil Sangith1, Perumal Kaliraj3,4, Sankaranarayanan Meenakshisundaram5.   

Abstract

Endemic countries with lymphatic filariasis are striving towards the Global Program to Eliminate Lymphatic Filariasis (GPELF) by 2020. Efficient and cost-effective diagnostic tools to assess active filarial infection are critical to eradicate lymphatic filariasis. Detection of circulating filarial antigens in sera is one of the precise methods to identify this infection. Monoclonal antibodies and single chain fragment variable (scFv) against Wuchereria bancrofti antigen SXP1 have been developed for antigen detection. Molecular cloning of scFv for recombinant expression has laid a platform for developing novel genetic constructs with enhanced reactivity. In this study, a simple procedure is developed to create diverse libraries of scFv based on a single DNA framework with all the requisites for an in vitro protein synthesis and ribosomal display. Error Prone-PCR was performed to incorporate random mutations and screened by ribosome display technique to isolate evolved scFv. Evolved scFv with six mutations showed tenfold increase in affinity compared to wild-type scFv for rWbSXP1. In silico studies showed that four mutations introduced unique molecular interactions between the evolved scFv and SXP1. Reactivity with asserted clinical samples of endemic normals (EN), microfilariaemic (MF), chronic pathology (CP) and non-endemic normals (NEN) showed significant augment (59.69%, p < 0.0001) in reactivity to MF samples with evolved scFv in comparison to wild-type scFv. Sensitivity of scFv was increased from 15.62 ng to 195 pg by evolved scFv in serum samples. This evolutionary method coupled with ribosome display has facilitated us to improve the reactivity of the ScFv without diminishing the specificity.

Entities:  

Keywords:  Detection; Lymphatic filariasis; Ribosome display; scFv

Mesh:

Substances:

Year:  2019        PMID: 31512046     DOI: 10.1007/s11033-019-04995-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

1.  Comparison of tests for the detection of circulating filarial antigen (Og4C3-ELISA and AD12-ICT) and ultrasound in diagnosis of lymphatic filariasis in individuals with microfilariae.

Authors:  Abraham Rocha; Cynthia Braga; Marcela Belém; Arturo Carrera; Ana Aguiar-Santos; Paula Oliveira; Maria José Texeira; André Furtado
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

2.  Virtual mutation and directional evolution of anti-amoxicillin ScFv antibody for immunoassay of penicillins in milk.

Authors:  Xin He; Chang Fei Duan; Yong Hua Qi; Jun Dong; Geng Nan Wang; Guo Xian Zhao; Jian Ping Wang; Jing Liu
Journal:  Anal Biochem       Date:  2016-10-22       Impact factor: 3.365

3.  Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.

Authors:  Joseph Kamgno; Hugues C Nana-Djeunga; Sébastien D Pion; Cédric B Chesnais; Amy D Klion; Charles D Mackenzie; Thomas B Nutman; Michel Boussinesq
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

4.  Antigen detection assay with parasite specific monoclonal antibodies for diagnosis of lymphatic filariasis.

Authors:  Vivek Pandey; Jayaprakasam Madhumathi; Anjali A Karande; Perumal Kaliraj
Journal:  Clin Chim Acta       Date:  2011-06-30       Impact factor: 3.786

5.  Construction and bacterial expression of a recombinant single-chain antibody fragment against Wuchereria bancrofti SXP-1 antigen for the diagnosis of lymphatic filariasis.

Authors:  R Kamatchi; J Charumathi; R Ravishankaran; P Kaliraj; S Meenakshisundaram
Journal:  J Helminthol       Date:  2016-01       Impact factor: 2.170

6.  The Wuchereria bancrofti orthologue of Brugia malayi SXP1 and the diagnosis of bancroftian filariasis.

Authors:  K V Rao; M Eswaran; V Ravi; B Gnanasekhar; R B Narayanan; P Kaliraj; K Jayaraman; A Marson; N Raghavan; A L Scott
Journal:  Mol Biochem Parasitol       Date:  2000-03-15       Impact factor: 1.759

7.  Development and evaluation of a rapid flow-through immuno filtration test using recombinant filarial antigen for diagnosis of brugian and bancroftian filariasis.

Authors:  Lakshmi Kanthan Vijaya Baskar; Tokuluva Ramalingam Srikanth; Salahudeen Suba; Himansu Chirag Mody; Pradeep Kumar Desai; Perumal Kaliraj
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

8.  Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.

Authors:  Collins S K Ahorlu; Eric Koka; Susan Adu-Amankwah; Joseph Otchere; Dziedzom Komi de Souza
Journal:  BMC Public Health       Date:  2018-02-13       Impact factor: 3.295

9.  Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.

Authors:  Kimberly Y Won; Keri Robinson; Katy L Hamlin; Joseph Tufa; Margaret Seespesara; Ryan E Wiegand; Katherine Gass; Joseph Kubofcik; Thomas B Nutman; Patrick J Lammie; Saipale Fuimaono
Journal:  PLoS Negl Trop Dis       Date:  2018-03-09

10.  Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial.

Authors:  Patrick J Lammie; Gary Weil; Rahmah Noordin; Perumal Kaliraj; Cathy Steel; David Goodman; Vijaya B Lakshmikanthan; Eric Ottesen
Journal:  Filaria J       Date:  2004-09-03
View more
  1 in total

1.  Development of Fluorescence Polarization Immunoassay With scFv to Detect Fumonisin Bs in Maize and Simultaneous Study of Their Molecular Recognition Mechanism.

Authors:  Yuan Li; Qing Yu; Wenbo Yu; Suxia Zhang; Kai Wen; Jianzhong Shen; Zhanhui Wang; Xuezhi Yu
Journal:  Front Chem       Date:  2022-02-21       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.